Furthermore, the expression of the transcription factor Glioma-associated oncogene homolog 1 (GLI) and Smoothened (SMO) are connected to the promotion of treatment resistance survival in AML [77, 78]. The gene discussed is SMO; the disease is acute myeloid leukemia.